DR. ROBERT IRA ABELS, MD
Osteopathic Medicine at Linden Ave, Westfield, NJ
License number
New Jersey 25MA02536100
Category
Osteopathic Medicine
Type
Allergy & Immunology
Address
Address
422 Linden Ave, Westfield, NJ 07090
Phone
(908) 654-7142
Organization information
See more information about ROBERT IRA ABELS at bizstanding.comRobert Ira Abels MD
422 Linden Ave, Westfield, NJ 07090
Categories:
Physicians & Surgeons
Phone:
(908) 654-7142 (Phone)
Professional information
Method For Treating Psoriasis
US Patent:
5466447, Nov 14, 1995
Filed:
Apr 21, 1994
Appl. No.:
8/230662
Inventors:
Robert I. Abels - Westfield NJ
Karen Reilly - Cranford NJ
Karen Reilly - Cranford NJ
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 4505
US Classification:
424 852
Abstract:
The present invention provides a therapeutic method of treating a human subject for psoriasis which comprises administering to the subject an effective psoriatic dermatosis-inhibiting amount of IL-2 and a pharmaceutically acceptable carrier.
Method For Increasing The Hematocrit Of A Normal Mammal
US Patent:
5541158, Jul 30, 1996
Filed:
Sep 19, 1989
Appl. No.:
7/409223
Inventors:
John F. A. Vance - Stowe VT
Robert I. Abels - Westfield NJ
Freedolph D. Anderson - Neshanic Station NJ
William L. Harris - Port Murray NJ
Dorothy Thompson - Hulmeville PA
Robert I. Abels - Westfield NJ
Freedolph D. Anderson - Neshanic Station NJ
William L. Harris - Port Murray NJ
Dorothy Thompson - Hulmeville PA
Assignee:
Ortho Pharmaceutical Corporation - Raritan NJ
International Classification:
A61K 3816, A61K 3514, A01N 3718, C07K 100
US Classification:
514 8
Abstract:
A method for increasing the hematocrit of a normal mammal using erythropoietin (EPO) is provided. The method comprises the steps of administering to the mammal a hematocrit increasing effective amount of EPO, in a pharmaceutically acceptable form. Additionally administered is an effective amount of iron, in a pharmaceutically acceptable form, sufficient to increase the serum iron content of the mammal to an erythropoiesis supportable level. The method is useful for increasing the amount of blood that can be donated for transfusion purposes, in particular autologous transfusion.